AntineoplasticsDrug resistance and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1953卷 / 1期

关键词：

D O I：

10.1007/s40278-023-37480-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：45 / 45

相关论文

共 50 条

[31] AntibacterialsDevelopment of resistance and lack of efficacy: case report
Reactions Weekly, 2021, 1836 (1) : 69 - 69
[32] AntineoplasticsDrug exposure during pregnancy and lack of efficacy: 3 case reports
Reactions Weekly, 2023, 1939 (1) : 50 - 50
[33] AntineoplasticsDrug induced pneumonitis, drug toxicity and lack of efficacy: 4 case reports
Reactions Weekly, 2025, 2042 (1) : 44 - 44
[34] AntineoplasticsDrug resistance to osimertinib and savolitinib and diarrhoea: case report
Reactions Weekly, 2017, 1643 (1) : 30 - 30
[35] AntineoplasticsDrug resistance in follicular lymphoma and haematotoxicity: case report
Reactions Weekly, 2017, 1639 (1) : 40 - 40
[36] AntineoplasticsDrug resistance secondary to acquired gene mutation: case report
Reactions Weekly, 2019, 1739 (1) : 36 - 36
[37] Multiple drugsDrug resistance and lack of efficacy: case report
Reactions Weekly, 2025, 2040 (1) : 615 - 615
[38] AntibacterialsAcquired drug resistance and lack of efficacy: case report
Reactions Weekly, 2024, 2035 (1) : 48 - 48
[39] Immunosuppressants/rituximabDrug resistance and lack of efficacy: case report
Reactions Weekly, 2021, 1875 (1) : 173 - 173
[40] Multiple drugsAcquired resistance and lack of efficacy: case report
Reactions Weekly, 2022, 1917 (1) : 376 - 376

← 1 2 3 4 5 →